|
Volumn 154, Issue 6, 1996, Pages 1623-1628
|
Treatment of cat allergy with T-cell reactive peptides
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLERGEN;
ALLERVAX CAT;
EPITOPE;
IMMUNOGLOBULIN E;
PEPTIDE;
PLACEBO;
UNCLASSIFIED DRUG;
ADULT;
ALLERGY;
AMINO ACID SYNTHESIS;
ARTICLE;
ASTHMA;
CAT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DISEASE ASSOCIATION;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FOREIGN BODY;
HUMAN;
HYPOTHESIS;
IMMUNOGLOBULIN BLOOD LEVEL;
IMMUNOLOGICAL TOLERANCE;
LYMPHOCYTE PROLIFERATION;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIGNAL TRANSDUCTION;
SKIN TEST;
SUBCUTANEOUS DRUG ADMINISTRATION;
T LYMPHOCYTE ACTIVATION;
TREATMENT PLANNING;
|
EID: 8044227212
PISSN: 1073449X
EISSN: None
Source Type: Journal
DOI: 10.1164/ajrccm.154.6.8970345 Document Type: Article |
Times cited : (361)
|
References (0)
|